Profile data is unavailable for this security.
About the company
Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and sales of bulk pharmaceutical chemicals of chemical medicine and preparations. The Company’s products are on the spectrum from arthritis, dieresis to anti-virus and anti-tumor. The main products include bulk pharmaceutical chemicals, injections, capsules, intermediates and others.
- Revenue in CNY (TTM)732.68m
- Net income in CNY166.02m
- Incorporated2001
- Employees738.00
- LocationZhejiang Cheng Yi Pharmaceutical Co LtdNo. 118 Huagong Road, Dongtou DistrictSHANGHAI 201100ChinaCHN
- Phone+86 2 133283295
- Fax+86 2 133283305
- Websitehttp://www.chengyipharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novoprotein Scientific Inc | 134.56m | -21.29m | 2.56bn | 579.00 | -- | 1.19 | -- | 19.02 | -0.3031 | -0.3031 | 1.92 | 30.57 | 0.0592 | 0.5833 | 1.96 | 232,406.80 | -0.937 | -- | -0.959 | -- | 61.17 | -- | -15.82 | -- | 34.60 | -- | 0.0323 | -- | -42.09 | -- | -85.84 | -- | -- | -- |
| Ginwa Enterprise Group Inc | 581.53m | -15.51m | 2.56bn | 553.00 | -- | 1.69 | -- | 4.41 | -0.0382 | -0.0382 | 1.58 | 4.07 | 0.2968 | 4.81 | 5.28 | 1,051,591.00 | -0.7916 | 0.3641 | -0.9515 | 0.4141 | 76.18 | 73.64 | -2.67 | 1.15 | 2.19 | 0.196 | 0.0431 | 124.25 | -2.41 | -5.37 | -228.19 | -- | 61.66 | -- |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 732.68m | 166.02m | 2.68bn | 738.00 | 16.17 | 2.16 | -- | 3.66 | 0.5072 | 0.5072 | 2.24 | 3.80 | 0.4013 | 2.01 | 17.68 | 992,793.70 | 9.07 | 12.01 | 11.17 | 14.75 | 66.13 | 69.79 | 22.60 | 22.84 | 1.01 | -- | 0.1998 | 36.44 | 2.54 | 4.24 | 0.8129 | 10.94 | -23.56 | 12.84 |
| Frontier Biotechnologies Inc | 133.67m | -279.96m | 2.82bn | 395.00 | -- | 2.45 | -- | 21.07 | -0.7474 | -0.7474 | 0.3569 | 3.07 | 0.0636 | 1.61 | 2.72 | 338,416.90 | -13.31 | -14.05 | -16.40 | -15.78 | 33.62 | 2.35 | -209.43 | -450.08 | 2.02 | -- | 0.2808 | -- | 34.82 | 126.63 | 7.79 | -- | 28.13 | -- |
Data as of Sep 13 2024. Currency figures normalised to Zhejiang Cheng Yi Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.68%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 1.98m | 0.61% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 1.57m | 0.48% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 941.20k | 0.29% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2024 | 372.70k | 0.11% |
| Gfund Management Co., Ltd.as of 30 Jun 2024 | 347.40k | 0.11% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2024 | 95.30k | 0.03% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 76.90k | 0.02% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2024 | 42.72k | 0.01% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024 | 40.80k | 0.01% |
| Fortune & Royal Asset Management Co., Ltd.as of 30 Jun 2024 | 28.50k | 0.01% |
More ▼
Data from 30 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
